About the book
Heart transplantation has been established as a definitive therapeutic strategy for patients with end-stage cardiac failure and its outcome was improved. However, long-term patient survival has been less improved due to many post-transplant complications. In this book, we would like to discuss topics concerning recent immunosuppression protocol and infection control after heart transplantation as well as complications after heart transplantation, such as antibody-mediated rejection, transplant coronary allograft vasculopathy, and posttransplant Lymphoproliferative disorder. Pediatric heart transplantation also increased up to 600/ year in the world. Pediatric heart transplantation has had special issues to be solved because a child is not a small adult. These issues, such as child growth and development, child care, special infection, immunosuppression will be discussed. Finally, patient death during waiting for heart transplantation has been also a big issue and mechanical circulatory support is one of the methods to solve this problem. The devices, such as ECMO, Impella, durable paracorporeal VAD, implantable VAD will be also discussed in terms of indication, strategies and outcome.